By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics developer Rules-Based Medicine said today that it will collaborate with the Institut Pasteur on a project aimed at gaining a better understanding of the human immune system.

RBM will use its TruCulture in vitro model in the project called Milieu Interieur to "establish the parameters that characterize the immune system of healthy individuals," RBM said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.